Pharma United SA
Pharma United reported total assets of 77,937 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
The score of Pharma United shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -33 % Total assets -21 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma United's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −63,433 € | ||||
| Equity | 62,229 € | ||||
| Cash | 2,631 € | ||||
| EBITDA | −63,361 € | ||||
| Total assets | 77,937 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 30 Jul 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 28 Aug 2022
Pharma United's financial analysis
- Solvency79.8%sector median: 56.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma United
Pharma United's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0645.674.560
- VAT number
- BE0645674560
- Peppol
- Registered · 0208:0645674560 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 07 Jan 2016
- Registered office
- 2960 Brecht
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Public relations and communication activities (NACE 73300)
Pharma United (SA) has been based in Brecht since 2016, active in: public relations and communication activities. For 2025, it reports a net loss of 63,433 € and equity of 62,229 €; its revenue is not published. Its solvency stands at 79.8%, above the median of its sector (56.8%).
Companies similar to Pharma United
Companies in the same business, of comparable size and area, outside its group.
- Prins Invest Public relations and communication activities Mechelen · balance sheet 77,940 €
- Sanael Consult Public relations and communication activities Ittre · balance sheet 77,798 €
- Fealfa Public relations and communication activities Sint-Lievens-Houtem · balance sheet 78,354 €
- Comprehos Public relations and communication activities Antwerp · balance sheet 77,181 €
- Altjv Public relations and communication activities Schaerbeek · balance sheet 77,132 €
- Comm-Unity Public relations and communication activities Beveren-Kruibeke-Zwijndrecht · balance sheet 77,101 €
- Avalom Public relations and communication activities Beauvechain · balance sheet 77,076 €
- In the arena Public relations and communication activities Zemst · balance sheet 79,133 €
Frequently asked questions about Pharma United
What is the revenue of Pharma United?
Pharma United files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma United?
In Belgium, the VAT number is the company number prefixed with BE: BE0645674560 for Pharma United, if the company is VAT-registered. Its company number (CBE) is 0645.674.560.
Where is the registered office of Pharma United?
According to the CBE register, the registered office of Pharma United is in 2960 Brecht.
What is the equity of Pharma United?
At the close of the 2025 financial year, the equity of Pharma United amounts to 62,229 €, a solvency of 79.8% of total assets.
Who manages Pharma United?
The register lists 2 active mandates at Pharma United. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma United
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →